Four things to know:
1. Dr. Borlongan is a professor and director of the center of excellence for aging and brain repair and professor of neurosurgery at USF Morsani College of Medicine.
2. He holds 16 patents and specializes in stem cell therapy for stroke.
3. Dr. Borlongan’s translational bench-to-clinic research culminated in five FDA-approved clinical trials of cell transplantation including a cell therapy product for stroke patients.
4. Together the five scientists have 63 patents that range from neuroscience to pharmaceutical chemistry.
More articles on spine:
Misonix ultrasonic device earns CE Mark approval — 4 insights
The future of spinal fusion: 4 spine surgeon predictions for 2019 & beyond
Academic panel to define best practices for outpatient stem cell procedure
